439 related articles for article (PubMed ID: 19148507)
1. Clinical significance of Smac/DIABLO expression in colorectal cancer.
Endo K; Kohnoe S; Watanabe A; Tashiro H; Sakata H; Morita M; Kakeji Y; Maehara Y
Oncol Rep; 2009 Feb; 21(2):351-5. PubMed ID: 19148507
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance.
Mizutani Y; Nakanishi H; Yamamoto K; Li YN; Matsubara H; Mikami K; Okihara K; Kawauchi A; Bonavida B; Miki T
J Clin Oncol; 2005 Jan; 23(3):448-54. PubMed ID: 15572731
[TBL] [Abstract][Full Text] [Related]
3. Galectin-3 expression is a potent prognostic marker in colorectal cancer.
Endo K; Kohnoe S; Tsujita E; Watanabe A; Nakashima H; Baba H; Maehara Y
Anticancer Res; 2005; 25(4):3117-21. PubMed ID: 16080575
[TBL] [Abstract][Full Text] [Related]
4. Disturbed XIAP and XAF1 expression balance is an independent prognostic factor in gastric adenocarcinomas.
Shibata T; Noguchi T; Takeno S; Gabbert HE; Ramp U; Kawahara K
Ann Surg Oncol; 2008 Dec; 15(12):3579-87. PubMed ID: 18807090
[TBL] [Abstract][Full Text] [Related]
5. Immunoexpression of inhibitors of apoptosis proteins and their antagonist SMAC/DIABLO in colorectal carcinoma: correlation with apoptotic index, cellular proliferation and prognosis.
De Oliveira Lima F; De Oliveira Costa H; Barrezueta LF; Fujiyama Oshima CT; Silva JA; Gomes TS; Pinheiro N; Neto RA; Franco M
Oncol Rep; 2009 Aug; 22(2):295-303. PubMed ID: 19578769
[TBL] [Abstract][Full Text] [Related]
6. Relationship between expression of Smac and Survivin and apoptosis of primary hepatocellular carcinoma.
Bao ST; Gui SQ; Lin MS
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):580-3. PubMed ID: 17085346
[TBL] [Abstract][Full Text] [Related]
7. [Expression of Smac in Stage I-II non-small cell lung cancer and its clinical significance].
Zhao JM; Zhu ZH; Wu QL; Hou JH; Huang XP; Zhang PY; Rong TH
Ai Zheng; 2006 May; 25(5):631-4. PubMed ID: 16687088
[TBL] [Abstract][Full Text] [Related]
8. Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression.
Zlobec I; Baker K; Minoo P; Jass JR; Terracciano L; Lugli A
Clin Cancer Res; 2008 Jan; 14(1):143-8. PubMed ID: 18172264
[TBL] [Abstract][Full Text] [Related]
9. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma.
Paik SS; Jang SM; Jang KS; Lee KH; Choi D; Jang SJ
Ann Surg Oncol; 2009 Feb; 16(2):297-303. PubMed ID: 19050975
[TBL] [Abstract][Full Text] [Related]
10. Role of Smac/DIABLO in cancer progression.
Martinez-Ruiz G; Maldonado V; Ceballos-Cancino G; Grajeda JP; Melendez-Zajgla J
J Exp Clin Cancer Res; 2008 Sep; 27(1):48. PubMed ID: 18822137
[TBL] [Abstract][Full Text] [Related]
11. Reduced expression of Apaf-1 in colorectal adenocarcinoma correlates with tumor progression and aggressive phenotype.
Paik SS; Jang KS; Song YS; Jang SH; Min KW; Han HX; Na W; Lee KH; Choi D; Jang SJ
Ann Surg Oncol; 2007 Dec; 14(12):3453-9. PubMed ID: 17882496
[TBL] [Abstract][Full Text] [Related]
12. Expression of standard CD44 in human colorectal carcinoma: association with prognosis.
Huh JW; Kim HR; Kim YJ; Lee JH; Park YS; Cho SH; Joo JK
Pathol Int; 2009 Apr; 59(4):241-6. PubMed ID: 19351367
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of BMP7 in human colorectal cancer.
Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M
Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822
[TBL] [Abstract][Full Text] [Related]
14. Expression of Smac/DIABLO in B-cell non-Hodgkin and Hodgkin lymphomas.
Ren Y; Akyurek N; Schlette E; Rassidakis GZ; Medeiros LJ
Hum Pathol; 2006 Nov; 37(11):1407-13. PubMed ID: 16949641
[TBL] [Abstract][Full Text] [Related]
15. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
[TBL] [Abstract][Full Text] [Related]
16. [Expression of COX-2 protein in colorectal carcinoma and the clinical implication].
Yao HB; Wu AG; Chen YJ; Tang BH
Di Yi Jun Yi Da Xue Xue Bao; 2005 Dec; 25(12):1524-8. PubMed ID: 16361154
[TBL] [Abstract][Full Text] [Related]
17. CLIC4, ERp29, and Smac/DIABLO derived from metastatic cancer stem-like cells stratify prognostic risks of colorectal cancer.
Deng YJ; Tang N; Liu C; Zhang JY; An SL; Peng YL; Ma LL; Li GQ; Jiang Q; Hu CT; Wang YN; Liang YZ; Bian XW; Fang WG; Ding YQ
Clin Cancer Res; 2014 Jul; 20(14):3809-17. PubMed ID: 24916695
[TBL] [Abstract][Full Text] [Related]
18. Nuclear expression of cIAP-1, an apoptosis inhibiting protein, predicts lymph node metastasis and poor patient prognosis in head and neck squamous cell carcinomas.
Tanimoto T; Tsuda H; Imazeki N; Ohno Y; Imoto I; Inazawa J; Matsubara O
Cancer Lett; 2005 Jun; 224(1):141-51. PubMed ID: 15911110
[TBL] [Abstract][Full Text] [Related]
19. Liver metastasis of colorectal cancer by protein-tyrosine phosphatase type 4A, 3 (PRL-3) is mediated through lymph node metastasis and elevated serum tumor markers such as CEA and CA19-9.
Hatate K; Yamashita K; Hirai K; Kumamoto H; Sato T; Ozawa H; Nakamura T; Onozato W; Kokuba Y; Ihara A; Watanabe M
Oncol Rep; 2008 Oct; 20(4):737-43. PubMed ID: 18813812
[TBL] [Abstract][Full Text] [Related]
20. Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer.
Zlobec I; Minoo P; Baumhoer D; Baker K; Terracciano L; Jass JR; Lugli A
Cancer; 2008 Feb; 112(3):495-502. PubMed ID: 18076013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
